Patent application number | Description | Published |
20090088708 | METHOD FOR TREATING A WOUND - A method for treating a wound with sutures is disclosed. One method includes placing the body and shaft of the device within a cavity of the wound; attaching a first end of at least one suture to a first side of the wound; passing a second end of the at least one suture through the body and coupling it to the shaft; attaching a second end of the at least one suture to the second side of the wound; and rotating the shaft with respect to the body to pull the first side of the wound and the second side of the wound toward one another. | 04-02-2009 |
20090287129 | METHOD OF TREATING A WOUND UTILIZING SUCTION - A therapeutic device for promoting the healing of a wound in a mammal is disclosed. An exemplary device comprises a permeable structure having a plurality of depressions formed in a surface thereof. In use, the surface having the depressions is disposed adjacent a surface of the wound. A method of treating a wound comprises the steps of providing a permeable structure comprising a plurality of randomly disposed fibers and having i) a plurality of wound surface contact elements disposed between end portions of the structure, and ii) a plurality of voids defined by the contact elements; and applying the permeable structure to at least one surface of the wound. | 11-19-2009 |
20100318046 | WOUND PACKING MATERIAL FOR USE WITH SUCTION - A wound packing for use with suction is provided. The wound packing comprises a plurality of nonabsorbent synthetic polymeric fibers coupled together to form a nonabsorbent material suitable for placement in the wound of a mammal. A method for treating the wound in a mammal using the disclosed wound packing is also provided. | 12-16-2010 |
20110270202 | GROWTH STIMULATING WOUND DRESSING WITH IMPROVED CONTACT SURFACES - A wound contact device comprising a permeable material and a wound contact layer having voids extending through the contact layer to a depth in the permeable material. The wound contact layer can comprise a thin sheet or film forming a generally flat and smooth wound contact surface having essentially no discontinuities or gaps. The wound contact layer can comprise a thin sheet of highly calendered fabric forming a wound contact surface having a mean surface roughness in the range of about 0 microns to about 200 microns. In progressive wound healing, an embodiment of the wound contact device having the fabric contact surface is used in earlier healing stages and an embodiment of the wound contact device with film contact surface is used in later healing stages. The wound contact device is particularly useful in wound dressings for use in suction-assisted wound therapy. | 11-03-2011 |
20130296815 | WOUND PACKING MATERIAL FOR USE WITH SUCTION - A wound packing for use with suction is provided. The wound packing comprises a plurality of nonabsorbent synthetic polymeric fibers coupled together to form a nonabsorbent material suitable for placement in the wound of a mammal. A method for treating the wound in a mammal using the disclosed wound packing is also provided. | 11-07-2013 |
Patent application number | Description | Published |
20120321553 | Ultrafiltration Concentration of Allotype Selected Antibodies for Small-Volume Administration - Disclosed are methods, compositions and uses of high concentration antibody or immunoglobulin formulations for subcutaneous, intramuscular, transdermal or other local (regional) administration, in a volume of than 3, less than 2 or less than 1 ml. Preferably, the formulation contains a high concentration formulation (HCF) buffer comprising phosphate, citrate, polysorbate 80 and mannitol at a pH of about 5.2. The formulation more preferably comprises at least 100, 150, 200, 250 mg/ml or 300 mg/ml of antibody. The methods for preparing the high concentration formulation include ultrafiltration and diafiltration to concentrate the antibody and exchange the medium for HCF buffer. Other embodiments concern use of non-G1m1 (nG1m1) allotype antibodies, such as G1m3 and/or a nG1m1,2 antibodies. The nG1m1 antibodies show decreased immunogenicity compared to G1m1 antibodies. | 12-20-2012 |
20140178294 | Ultrafiltration Concentration of Allotype Selected Antibodies for Small-Volume Administration - Disclosed are methods, compositions and uses of high concentration antibody or immunoglobulin formulations for subcutaneous, intramuscular, transdermal or other local (regional) administration, in a volume of than 3, less than 2 or less than 1 ml. Preferably, the formulation contains a high concentration formulation (HCF) buffer comprising phosphate, citrate, polysorbate 80 and mannitol at a pH of about 5.2. The formulation more preferably comprises at least 100, 150, 200, 250 mg/ml or 300 mg/ml of antibody. The methods for preparing the high concentration formulation include ultrafiltration and diafiltration to concentrate the antibody and exchange the medium for HCF buffer. Other embodiments concern use of non-G1m1 (nG1m1) allotype antibodies, such as G1m3 and/or a nG1m1,2 antibodies. The nG1m1 antibodies show decreased immunogenicity compared to G1m1 antibodies. | 06-26-2014 |
20140193359 | Ultrafiltration Concentration of Allotype Selected Antibodies for Small-Volume Administration - Disclosed are methods, compositions and uses of high concentration antibody or immunoglobulin formulations for subcutaneous, intramuscular, transdermal or other local (regional) administration, in a volume of than 3, less than 2 or less than 1 ml. Preferably, the formulation contains a high concentration formulation (HCF) buffer comprising phosphate, citrate, polysorbate 80 and mannitol at a pH of about 5.2. The formulation more preferably comprises at least 100, 150, 200, 250 mg/ml or 300 mg/ml of antibody. The methods for preparing the high concentration formulation include ultrafiltration and diafiltration to concentrate the antibody and exchange the medium for HCF buffer. Other embodiments concern use of non-G1m1 (nG1m1) allotype antibodies, such as G1m3 and/or a nG1m1,2 antibodies. The nG1m1 antibodies show decreased immunogenicity compared to G1m1 antibodies. | 07-10-2014 |
Patent application number | Description | Published |
20090205713 | Carbon Nanotubes As Charge Carriers In Organic and Hybrid Solar Cells - Organic and organic/inorganic hybrid bulk heterojunction photovoltaic devices with improved efficiencies are disclosed. The organic photovoltaic device comprises a photoactive polymer:fullerene C | 08-20-2009 |
20090283475 | Carbon Nanotube Mediated Membrane Extraction - The present disclosure provides an improved membrane or substrate having carbon nanotubes introduced and/or immobilized therein, and an improved method for introducing and/or immobilizing carbon nanotubes in membranes or substrates. More particularly, the present disclosure provides for improved systems and methods for fabricating membranes or substrates having carbon nanotubes immobilized therein. In one embodiment, the present disclosure provides for systems and methods for introducing and/or immobilizing functionalized carbon nanotubes into the pore structure of a polymeric membrane or substrate, thereby dramatically improving the performance of the polymeric membrane or substrate. In exemplary embodiments, the present disclosure provides for systems and methods for the fabrication of nanotube immobilized membranes by incorporating CNTs in a membrane or substrate. | 11-19-2009 |
20090304923 | Microwave Synthesis of Metal-Carbon Nanotube Composites - The present disclosure provides for improved soluble carbon nanotube (“CNT”) composites at least partially coated with a metal material, and improved methods for the synthesis, generation or formation of substantially soluble carbon nanotube composites via heating conditions (e.g., microwave reactions). For example, the present disclosure provides for methods for the rapid, controllable, environmentally-friendly formation of substantially soluble carbon nanotube composites via in-situ microwave-assisted reactions, wherein the carbon nanotube composites are at least partially coated with nanometal particles (e.g., nanoplatinum particles), and wherein the nanocomposites are substantially soluble in water and/or in organic solvents (e.g., o-dichlorobenzene (ODCB), chloroform, tetrahydrofuran (THF), ethanol, toluene, hexane and DMF). | 12-10-2009 |
20100086470 | Rapid microwave process for purification of nanocarbon preparations - A novel microwave-assisted process is described for the rapid removal of catalytic metal and non-desirable carbon impurities in fullerene, single wall, and multiple wall carbon nanotube preparations. The purification process is carried out at various programmed pressures, power levels and reaction times in a suspension of the nanocarbon moieties in the presence of strong acids (for example, a mixture of sulfuric acid and nitric acid), in weak acids (for example, acetic acid) and in the presence of chelating agents (for example, EDTA—ethylenediaminetetraacetic acid). In one embodiment, high metal removal efficiency of 70 to 90% is observed. | 04-08-2010 |
20100326813 | Microwave Induced Functionalization of Single Wall Carbon Nanotubes and Composites Prepared Therefrom - The invention is directed to a method of forming, producing or manufacturing functionalized nanomaterials, and, specifically, soluble functionalized nanomaterials. The presently described invention also relates to nanomaterial-based composites consisting of a target material, which can include ceramic, polymer, or metallic matrices incorporated into or grown on nanomaterials, as well as a method or synthesis technique for the formation, production, or manufacture of nanomaterial-based composites through microwave-induced reaction. | 12-30-2010 |
20110271838 | MICROTRAP ASSEMBLY FOR GREENHOUSE GAS AND AIR POLLUTION MONITORING - A microtrap assembly includes a carbon nanotube sorbent. The microtrap assembly may be employed as a preconcentrator operable to deliver a sample to an analytical device to measure the concentrations of greenhouse gases. A system includes a microtrap having a carbon nanotube sorbent for measuring the concentrations of greenhouse gases in a sample. | 11-10-2011 |
20110272354 | Membrane Distillation Apparatus and Methods - Membranes for membrane distillation include at least one hollow fiber porous hydrophobic membrane, the at least one membrane including carbon nanotubes incorporated into the pore structure of the membrane. Membrane distillation systems may include a heat exchanger operably connected to a hollow fiber membrane module with one or more membranes including carbon nanotubes. Methods of solvent removal, sample preconcentration and desalination employing hollow fiber porous hydrophobic membranes with carbon nanotubes are disclosed. | 11-10-2011 |
20140199578 | FLEXIBLE ALKALINE BATTERY - This invention presents the development of flexible battery especially primary and secondary alkaline batteries. Nano carbons, in particularly carbon nanotubes are implemented in conductive polymers to develop flexible electrodes. Polymer separators that can withstand high pH and serve the purpose of electrolyte storage is used to enhance performance. The relatively inexpensive multiwall nanotubes represent are effective ingredients in development of flexible electrodes. | 07-17-2014 |